Stromal myofibroblasts predict disease recurrence for colorectal cancer

Clinical Cancer Research

Volumn 13, Issue 7, 2007, Pages 2082-2090

  Tsujino, Tadashi ^a   Seshimo, Iwao ^a   Yamamoto, Hirofumi ^a,b   Chew, Yee Ngan ^a   Ezumi, Koji ^a   Takemasa, Ichiro ^a   Ikeda, Masataka ^a   Sekimoto, Mitsugu ^a   Matsuura, Nariaki ^a   Monden, Morito ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BIOLOGICAL MARKER; COLLAGEN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; COMPARATIVE STUDY; COMPUTER ANALYSIS; DEMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROGNOSIS; STROMA; SURVIVAL RATE;

ACTINS; AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FIBROBLASTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 34247503111     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-06-2191     Document Type: Article

References (37)

1. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 1986;315:1650-9.
2. Kinzler KW, Vogelstein B. Landscaping the cancer terrain. Science 1998;280:1036-7.
3. Ronnov-Jessen L, Petersen OW, Bissell MJ. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996;76:69-125.
4. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
5. Gabbiani G, Ryan GB, Majne G. Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction. Experientia 1971;27:549-50.
6. Barsky SH, Green WR, Grotendorst GR, Liotta LA. Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol 1984;115:329-33.
7. Yen TWF, Aardal NP, Bronner MP, et al. Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas. Surgery 2002;131:129-34
8. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63:144-61.
9. Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix. Lab Invest 1983;49:636-49.
10. Barsky SH, Gopalakrishna R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res 1987;47:1663-7.
11. Peyrol S, Raccurt M, Gerard F, Gleyzal C, Grimaud JA, Sommer P. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma. Am J Pathol 1997;150:497-507.
12. Camps JL, Chang SM, Hsu TC, et al. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc Natl Acad Sci U S A 1990;87:75-9.
13. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002-11.
14. Skobe M, Fusenig NE. Tumorigenic conversion of immortal human keratinocytes stromal cell activation. Proc Natl Acad Sci U S A 1998;95:1050-5.
15. Gregoire M, Lieubeau B. The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 1995;14:339-50.
16. Sobin LH, Wittekind CH. editors. International Union Against Cancer (UICC). TNM classification of malignant tumors. 6th ed. New York; John Wiley & Sons, Inc.; 2002.
17. Noura S, Yamamoto H, Ohnishi T, et al. Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry. J Clin Oncol 2002;20:4232-41.
18. Yamamoto H, Kondo M, Nakamori S, et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis. Gastroenterology 2003;125:556-71.
19. Hayashi N, Yamamoto H, Hiraoka N, et al. Differential expression of cyclooxygenase-2 (COX-2) in epithelial cells and bile duct neoplasm. Hepatology 2001;34:638-50.
20. Graham DM, Appelman HD. Crohn's-like lymphoid reaction and colorectal carcinoma: a potential histologic prognosticator. Mod Pathol 1990;3:332-5.
21. Jass JR, Love SB, Northover JMA. A new prognostic classification of rectal cancer. Lancet 1987;1:1303-6.
22. Schmitt-Graff A, Kruger S, Bochard F, Gabbiani G, Denk H. Modulation of α smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991;138:1233-42.
23. Ander T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343-51.
24. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumor stroma in cancer. Nat Rev Cancer 2004;4:839-49.
25. Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia, and survival in colorectal cancer. J Clin Pathol 1989;42:162-6.
26. Cardone A, Tolino A, Zarcone R, Borruto Caracciolo G, Tartaglia E. Prognostic value of desmoplastic reaction and in the management of breast cancer. Panminerva Med 1997;39:174-7.
27. Jass JR, Atkin WS, Cuzick J, et al. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cancer-associated stromas. Histopathology 1986;10:437-59.
28. Lieubeau B, Garrigue L, Barbieux I, Meflah K, Gregoire M. The role of transforming growth factor β1 in the fibroblastic reaction associated with rat colorectal tumor development. Cancer Res 1994;54:6526-32.
29. Benson AB III, Schrag D, Somerfield MR, et al. American Society of Clinical Oncology recommendation on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 2004;22:3408-19.
30. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res 1997;57:3305-13.
31. Vogetseder W, Feichtinger H, Schulz TF, et al. Expression of 7F7-antigen, a human adhesion molecule identical to intercellular adhesion molecule-1 (ICAM-1) in human carcinomas and their stromal fibroblasts. Int J Cancer 1989;43:768-73.
32. Orimo A, Tomioka Y, Shimizu Y, et al. Cancer-associated myofibroblasts possess various factors to promote endometrial tumor progression. Clin Cancer Res 2001;7:3097-105.
33. Olumi AF, Dazin P, Tlsty TD. A novel coculture technique demonstrates that normal human prostatic fibroblasts contribute to tumor formation of LNCaP cells by retarding cell death. Cancer Res 1998;58:4524-30.
34. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
35. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;XII:309-20.
36. Astler VB, Colter FA. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 1954;139:846-52.
37. Elenbaas B, Weinberg RA. Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation. Exp Cell Res 2001;264:169-84.